Antibacterial, antifungal, anti-oxidant, anti-inflammatory and anti-hypertensive activities of N-chloropyrazinamide

• Autorzy: Vaijayanthi S. P. , Mathiyalagan N.
• Języki publikacji: EN

Abstrakty

EN

N-chloropyrazinamide was prepared by the chlorination of pyrazinamide using trichloroisocyanuric acid. The experimental results ascertained that the tested N-chloropyrazinamide showed good antimicrobial activities when compared to standard drug. It was found that N-chloropyrazinamide at different concentrations exhibited significant dose dependent anti-oxidant, anti-inflammatory and anti-hypertensive activity.

Słowa kluczowe

EN

antibacterial activity; antifungal activity; antioxidant activity; anti-inflammatory; anti-hypertensive activity; N-chloropyrazinamide

• Wydawca: Przedsiębiorstwo Wydawnictw Naukowych "DARWIN"
• Czasopismo: International Letters of Chemistry, Physics and Astronomy
• Rocznik: 2014
• Tom: Vol. 7
• Strony: 1--8
• Opis fizyczny: Bibliogr. 20 poz., tab.

Twórcy

autor

Vaijayanthi S. P.

• Department of Chemistry, M.A.M. College of Engineering and Technology, Siruganur, Tiruchirappalli - 621 105, Tamil Nadu, India

autor

Mathiyalagan N.

• Department of Chemistry, Jayaram College of Engineering and Technology, Karattampatti - Pagalavadi, Thuraiyur (Tk), Tiruchirappalli - 621 014, Tamil Nadu, India

Bibliografia

• [1] Michael H. Cynamon, Sally P. Klemens, Tso Sheng Chou, Rayomand H. Gimi, John T. Welch, Journal of Medicinal Chemistry 35 (1992) 1212-1215.
• [2] Setsuko Yamamoto, Ichiro Toida, Nanao Watanabe, Toshikazu Ura, Antimicrobial Agents and Chemotherapy 39(9) (1995) 2088-2091.
• [3] Veronika Opletalova, Jiri Hartl, Asmita Patel, Karel Palat Jr, Vladimir Buchta, Farmaco 57 (2002) 135-144.
• [4] Martin Dolezal, Lenka Tumova, Diana Kesetovicova, Jiri Tuma, Katarina Kraloya, Molecules 12(12) (2007) 2589-2598.
• [5] Martin Dolezal, Lukas Palek, Jarmila Vinsova, Vladimir Buchta, Josef Jampilek, Katarina Kraloya, Molecules 11(4) (2006) 242-256.
• [6] A. W. Cuthbert, J. M. Edwardson, Journal of Pharmacy and Pharmacology 31(6) (1979) 382-386.
• [7] B. A. Ellsworth, et. al., Bioorganic Medicinal Chemistry Letters 17(14) (2007) 3978-3982.
• [8] Martin Dolezal, Jan Zitko, Diana Kesetovicova, Jiri Kunes, Michaela Svobodova, Molecules 14(10) (2009) 4180-4189.
• [9] Lenka Tumova, Jiri Tuma, Klara Megusar, Marin Dolezal, Molecules 15(1) (2010) 331-340.
• [10] M. Dolezal, J. Zitko, Z. Osicka, J. Kunes, M. Vejsova, V. Buchta, J. Dohnal, J. Jampilek, K. Kralova, Molecules 15(12) (2010) 8567-8581.
• [11] Lenka Tumova, Jiri Tuma, Martin Dolezal, Molecules 16(11) (2011) 9142-9152.
• [12] S. Suzuki, A. Inoue, Chemical Abstracts 113 (1990) 218276t.
• [13] T. Sado, A. Inoue, Chemical Abstracts 113 (1990) 78422k.
• [14] Talaat Ibrahim El-Emary, Journal of Chinese Chemical Society 53(2) (2006) 391-401.
• [15] H. S. El-Kashef, T. I. El-Emary, M. Gasquet, P. Timon-David, J. Maldonado, P. Vanelle, Pharmazie 55(8) (2000) 572-576.
• [16] S. Parimala Vaijayanthi, N. Mathiyalagan, International Journal of Research in Organic Chemistry 2(3) (2012) 13-15.
• [17] S. K. Ling, T. Tanaka, I. Kouno, Biological & Pharmaceutical Bulletin 26(3) (2003) 352-356.
• [18] S. Kumar, D. Kumar, Manjusha, K. Saroha, N. Singh, B. Vashishta, Acta Pharmaceutica 58 (2008) 215-220.
• [19] V. K. Jimsheena, Analytical Chemistry 81 (2009) 9388-9394.
• [20] Nigel M. Hooper, Anthony J. Turner, Biochemical Journal 241 (1987) 625-633.